Mucosal malignant melanoma
Conditions
Interventions
None listed
Sponsors
The Research Project with Heavy Ions at the National Institute of radiological Sciences (NIRS)-Heavy Ion Medical Accelerator in Chiba (HIMAC).
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients treated with C-ion RT alone. All tumors were pathologically confirmed. The patients had medically inoperable tumors or declined surgery.
Exclusion criteria
Exclusion criteria: All patients received C-ion RT as the primary treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-year overall survival rate | — |
Secondary
| Measure | Time frame |
|---|---|
| 5-year local control rate, Toxicities (acute and late) | — |
Countries
Japan
Contacts
Public ContactKoto Masashi
National Institutes for Quantum and Radiological Sciences and Technology National Institute of Radiological Science Hospital
Outcome results
None listed